Review Article

Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases

Table 1

Effects of different phytochemicals on GM and/or obesity with anti-inflammatory actions.

PhytochemicalsCompoundModelEffect on gut microbiotaAntioxidant and anti-inflammatory effectEffect on obesityRef

PolyphenolsC57BL/6 J ApcMin miceBacterial diversity was higher in the bilberry group than in the other groupsAttenuation of inflammation in cloudberry-fed mice[183]
FlavononesBaicaleinC57BL/6 J miceSuppress activation of NF-κB and decrease expression of iNOS and TGF-βActivation of AMPK pathway and suppression of fatty acid synthesis, gluconeogenesis, and increased mitochondrial oxidation[184]
CatechinsEpigallocatechin-3-gallateC57BL/6 J miceThe Firmicutes/Bacteroidetes ratio is significantly lower in HFD + EGCG but higher in control diet + EGCGPotential use for prevention, or therapy, for obesity-related and oxidative stress-induced health risks[185]
Epigallocatechin-3-gallateC57BL/6 J miceRegulates the dysbiosis and maintains the microbial ecology balanceSignificant protective effect against obesity induced by high-fat diet (HFD)[186]
Epigallocatechin-3-gallateWistar ratsEGCG affects the growth of certain species of GMWeights of abdominal adipose tissues fed 0.6% EGCG diet were suppressed. Regulated energy metabolism in the body[187]
QuercetinC57BL/6 J miceAn increase in Firmicutes/Bacteroidetes ratio and in gram-negative bacteria and increased in Helicobacter by HFD. Quercetin treatment benefits GM balanceQuercetin reverted dysbiosis-mediated Toll-like receptor 4 (TLR-4) NF-κB signaling pathway activation and related endotoxemia, with subsequent inhibition of inflammasome response and reticulum stress pathway activationBenefits gut-liver axis activation associated to obesity, leading to the blockage of lipid metabolism gene expression deregulation[109]
QuercetinWistar ratsQuercetin supplementation attenuates Firmicutes/Bacteroidetes ratio and inhibiting the growth of bacterial species previously associated to diet-induced obesity (Erysipelotrichaceae, Bacillus, Eubacterium cylindroides). Quercetin was effective in lessening high-fat sucrose diet-induced GM dysbiosis[188]
QuercetinFischer 344 ratsExerts prebiotic properties by decreased pH, increased butyrate production, and altered GMOnion extract increased glutathione reductase (GR) and glutathione peroxidase (GPx1) activities in erythrocytes. In contrast, g-glutamate cysteine ligase catalytic subunit gene expression was upregulated[189]
Kaempferol3 T3-L1 adipocytesKaempferol reduced LPS proinflammatory action. Demonstrating the anti-inflammatory and antioxidant effectsConcomitantly, polyphenols increased the production of adiponectin and PPARγ, known as key anti-inflammatory and insulin-sensitizing mediators[110]
AnthocyaninsC57BL/6 J miceFeces of GM-deficient mice showed an increase in anthocyanins and a decrease in their phenolic acid metabolites, while a corresponding increase was observed in jejunum tissueMice with intact GM reduced body weight gain and improved glucose metabolism[190]
AnthocyaninsC57BL/6 J miceAnthocyanins could effectively reduce the expression levels of IL-6 and TNFα genes, markedly increasing SOD and GPx activityAnthocyanins reduced body weight could also reduce the size of adipocytes, leptin secretion, serum glucose, triglycerides, total cholesterol, LDL-cholesterol, and liver triglycerides[191]
Phenolic acidCurcuminMiceA direct effect of bioactive metabolites reaching the adipose tissue rather than from changes in GM compositionNutritional doses of Curcuma longa is able to decrease proinflammatory cytokine expression in subcutaneous adipose tissueAn effect independent of adiposity, immune-cell recruitment, angiogenesis, or modulation of GM controlling inflammation[192]
CurcuminLDLR−/− miceCurcumin improves intestinal barrier function and prevents the development of metabolic diseasesSignificantly attenuated the Western diet-induced increase in plasma LPS levelsSignificantly reduced WD-induced glucose intolerance and atherosclerosis[193]
CurcuminHuman IEC lines Caco-2 and HT-29Curcumin modulates chronic inflammatory diseases by reducing intestinal barrier dysfunction despite poor bioavailabilityCurcumin significantly attenuated LPS-induced secretion of master cytokine IL-1β from IEC and macrophages. Also reduced IL-1β-induced activation of p38 MAPK in IEC and subsequent increase in expression of myosin light-chain kinaseCurcumin attenuates WD-induced development of type 2 diabetes mellitus and atherosclerosis[194]
StilbenesResveratrolKunming miceHF microbiomes were clearly different from those in CT and HF-RES mice. After treatment, Lactobacillus and Bifidobacterium were significantly increased, whereas Enterococcus faecalis was significantly decreased, resulting in a higher abundance of Bacteroidetes and a lower abundance of FirmicutesTreatment inhibited increases in body and fat weight in HF mice. Decreased blood glucose to control levels, decreased blood insulin and serum total cholesterol compared with HF mice. Severe steatosis seen in HF mice was well prevented in treated mice. Treatment significantly suppressed expression of PPAR-γ, Acc1, and Fas, suggesting inhibition of triglyceride storage in adipocytes[195]
ResveratrolGlp1r−/− miceTreatment modified GMDecreased the inflammatory status of miceGlucoregulatory action of RSV in HFD-fed diabetic wild-type mice, in part through modulation of the enteroendocrine axis in vivo[196]
ResveratrolWistar ratsTrans-resveratrol supplementation alone or in combination with quercetin scarcely modified the GM profile but acted at the intestinal level, altering mRNA expression of tight-junction proteins and inflammation-associated genesAltering mRNA expression of tight-junction proteins and inflammation-associated genesAdministration of resveratrol and quercetin together prevented body weight gain and reduced serum insulin levels. Effectively reduced serum insulin levels and insulin resistance[188]
ResveratrolAdipocytesGenerally, resveratrol opposed the effect induced by LPS, functioning as an ameliorating factor in disease stateLPS altering glycosylation processes of the cell. Resveratrol ameliorates dysfunctioning adipose tissue induced by inflammatory stimulation[197]
ResveratrolHumansSteroid metabolism of the affected GM should be studied in detailSubtle but robust effects on several metabolic pathways[198]
PiceatannolC57BL/6 micePic altered the composition of the GM by increasing Firmicutes and Lactobacillus and decreasing BacteroidetesPic significantly reduced mouse body weight in a dose-dependent manner. Significantly decreased the weight of liver, spleen, perigonadal, and retroperitoneal fat compared with the HFD group. Pic significantly reduced adipocyte cell size of perigonadal fat and decreased weight of liver[199]
PiceatannolZucker obese ratsIt did not modify the profusion of the most abundant phyla in GM, though slight changes were observed in the abundance of several Lactobacillus, Clostridium, and Bacteroides species belonging to Firmicutes and BacteroidetesShows a tendency to reduce plasma LPS by 30%Pic did not reduce either hyperphagia or fat accumulation. There is a tendency toward the decrease of circulating on-esterified fatty acids, LDL-cholesterol, and lactate. While Pic tended to improve lipid handling, it did not mitigate hyperinsulinemia and cardiac hypertrophy[155]
Organosulfur compoundsGEO (garlic essential oil)
DADS (DiAllyl DiSulfide)
C57BL/6 miceSignificantly decreased the release of proinflammatory cytokines in liver, accompanied by elevated antioxidant capacity via inhibition of cytochrome P450 2E1 expressionGEO and DADS dose-dependently exerted antiobesity and antihyperlipidemic effects by reducing HFD-induced body weight gain, adipose tissue weight, and serum biochemical parameters[200]